Adverse events in patients with leprosy on treatment with thalidomide
Abstract INTRODUCTION: Thalidomide, used to treat erythema nodosum leprosum (ENL), is associated with severe adverse events (AEs) and is highly teratogenic. METHODS: A cross-sectional study was conducted on thalidomide-treated patients with ENL. AEs and selected variables were investigated through i...
Published in: | Revista da Sociedade Brasileira de Medicina Tropical |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2019
|
Subjects: | |
Online Access: | https://doi.org/10.1590/0037-8682-0385-2018 https://doaj.org/article/82ec0c99fb7545c699267d62370e3879 |
id |
ftdoajarticles:oai:doaj.org/article:82ec0c99fb7545c699267d62370e3879 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:82ec0c99fb7545c699267d62370e3879 2023-05-15T15:00:15+02:00 Adverse events in patients with leprosy on treatment with thalidomide Paula Lana de Miranda Drummond Roberta Márcia Marques dos Santos Gabriela Oliveira Carvalho Cristiane Aparecida Menezes de Pádua 2019-04-01T00:00:00Z https://doi.org/10.1590/0037-8682-0385-2018 https://doaj.org/article/82ec0c99fb7545c699267d62370e3879 EN eng Sociedade Brasileira de Medicina Tropical (SBMT) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100639&lng=en&tlng=en https://doaj.org/toc/1678-9849 1678-9849 doi:10.1590/0037-8682-0385-2018 https://doaj.org/article/82ec0c99fb7545c699267d62370e3879 Revista da Sociedade Brasileira de Medicina Tropical, Vol 52, Iss 0 (2019) Thalidomide Leprosy Adverse events Pharmacovigilance Drug safety Arctic medicine. Tropical medicine RC955-962 article 2019 ftdoajarticles https://doi.org/10.1590/0037-8682-0385-2018 2022-12-31T03:21:51Z Abstract INTRODUCTION: Thalidomide, used to treat erythema nodosum leprosum (ENL), is associated with severe adverse events (AEs) and is highly teratogenic. METHODS: A cross-sectional study was conducted on thalidomide-treated patients with ENL. AEs and selected variables were investigated through interviews and assessment of medical records. Odds ratios with 95% confidence intervals were estimated via logistic regression. RESULTS: Peripheral neuropathy symptoms and deep vein thrombosis (DVT) were the most common AEs reported. Although women of reproductive age used contraceptives, <50% of patients reported using condoms. Polypharmacy was associated with all endpoints, except DVT. CONCLUSIONS: Pharmacovigilance is crucial to prevent harmful thalidomide-associated AEs. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Revista da Sociedade Brasileira de Medicina Tropical 52 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Thalidomide Leprosy Adverse events Pharmacovigilance Drug safety Arctic medicine. Tropical medicine RC955-962 |
spellingShingle |
Thalidomide Leprosy Adverse events Pharmacovigilance Drug safety Arctic medicine. Tropical medicine RC955-962 Paula Lana de Miranda Drummond Roberta Márcia Marques dos Santos Gabriela Oliveira Carvalho Cristiane Aparecida Menezes de Pádua Adverse events in patients with leprosy on treatment with thalidomide |
topic_facet |
Thalidomide Leprosy Adverse events Pharmacovigilance Drug safety Arctic medicine. Tropical medicine RC955-962 |
description |
Abstract INTRODUCTION: Thalidomide, used to treat erythema nodosum leprosum (ENL), is associated with severe adverse events (AEs) and is highly teratogenic. METHODS: A cross-sectional study was conducted on thalidomide-treated patients with ENL. AEs and selected variables were investigated through interviews and assessment of medical records. Odds ratios with 95% confidence intervals were estimated via logistic regression. RESULTS: Peripheral neuropathy symptoms and deep vein thrombosis (DVT) were the most common AEs reported. Although women of reproductive age used contraceptives, <50% of patients reported using condoms. Polypharmacy was associated with all endpoints, except DVT. CONCLUSIONS: Pharmacovigilance is crucial to prevent harmful thalidomide-associated AEs. |
format |
Article in Journal/Newspaper |
author |
Paula Lana de Miranda Drummond Roberta Márcia Marques dos Santos Gabriela Oliveira Carvalho Cristiane Aparecida Menezes de Pádua |
author_facet |
Paula Lana de Miranda Drummond Roberta Márcia Marques dos Santos Gabriela Oliveira Carvalho Cristiane Aparecida Menezes de Pádua |
author_sort |
Paula Lana de Miranda Drummond |
title |
Adverse events in patients with leprosy on treatment with thalidomide |
title_short |
Adverse events in patients with leprosy on treatment with thalidomide |
title_full |
Adverse events in patients with leprosy on treatment with thalidomide |
title_fullStr |
Adverse events in patients with leprosy on treatment with thalidomide |
title_full_unstemmed |
Adverse events in patients with leprosy on treatment with thalidomide |
title_sort |
adverse events in patients with leprosy on treatment with thalidomide |
publisher |
Sociedade Brasileira de Medicina Tropical (SBMT) |
publishDate |
2019 |
url |
https://doi.org/10.1590/0037-8682-0385-2018 https://doaj.org/article/82ec0c99fb7545c699267d62370e3879 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista da Sociedade Brasileira de Medicina Tropical, Vol 52, Iss 0 (2019) |
op_relation |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100639&lng=en&tlng=en https://doaj.org/toc/1678-9849 1678-9849 doi:10.1590/0037-8682-0385-2018 https://doaj.org/article/82ec0c99fb7545c699267d62370e3879 |
op_doi |
https://doi.org/10.1590/0037-8682-0385-2018 |
container_title |
Revista da Sociedade Brasileira de Medicina Tropical |
container_volume |
52 |
_version_ |
1766332364910231552 |